Recent Updates
Recently added Catalysts
RDGT

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Shareholders of Ridgeline International Limited. Opinion on the Consolidated Financial Statements We have audited the accompanying con

Key Takeaway: Ridgeline International Limited has released its consolidated financial statements for the year ended March 31, 2024, which were audited by an independent firm. The reports indicate that the company has achieved a net income of $167,438 and total revenues of $78,360,705. The audit confirmed that the financial statements accurately reflect the company's financial position and comply with U.S. GAAP. Additionally, the financials reveal significant current liabilities primarily due to accounts payable.

Market Sentiment Analysis

Full Press Release Details

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
To the Board of Directors and
Shareholders of Ridgeline International Limited.
Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated
balance sheet of Ridgeline International Limited and subsidiaries (collectively, the "Company") as of March 31, 2024 and the
related consolidated statements of operations and comprehensive income, and cash flows for the year ended March 31, 2024, and the related
notes (collectively referred to as the "consolidated financial statements"). In our opinion, the consolidated financial statements
referred to above present fairly, in all material respects, the financial position of the Company as of March 31 2024, and the results
of its operations and its cash flows for the year ended March 31, 2024, in conformity with accounting principles generally accepted in
the United States of America.
These consolidated financial statements are the
responsibility of the Company's management. Our responsibility is to express an opinion on the Company's consolidated financial
statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States)
("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws
and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated
financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we
engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding
of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company's
internal control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing procedures to assess
the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures
that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the
consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by
management, as well as evaluating the overall presentation of the financial statement. We believe that our audit provides a reasonable
basis for our opinion.
We have served as the Company's auditor since 2025.
RIDGELINE INTERNATIONAL LIMITED AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
March 31,
2024
ASSETS
CURRENT ASSETS
Cash and cash equivalents $ 1,613,848
Restricted cash 4,089,442
Accounts receivable 3,846,390
Inventories 7,668,388
Advances to suppliers 309,519
Other receivables, net 24,728
Other current assets 316,197
Total current assets 17,868,512
NON-CURRENT ASSETS
Property and equipment, net 41,022
Other noncurrent assets 162
Total non-current assets 41,184
Total assets $ 17,909,696
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable $ 11,700,657
Notes payable 4,775,352
Other payables 40,059
Customer deposits 1,166,919
Taxes payable 21,606
Accrued liabilities 276
Total current liabilities 17,704,869
NON-CURRENT LIABILITIES
Total non-current liabilities -
Total liabilities 17,704,869
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS' EQUITY
Common stock 121,392
Accumulated deficit 79,444
Accumulated other comprehensive income(loss) 3,991
Total shareholders' equity 204,827
Total liabilities and shareholders' equity $ 17,909,696
The accompanying notes are an integral part of
these consolidated financial statements.
RIDGELINE INTERNATIONAL LIMITED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE
For the year ended March 31, 2024
REVENUES, NET $ 78,360,705
COST OF GOODS SOLD 77,016,399
GROSS PROFIT 1,344,306
SELLING EXPENSES 865,221
GENERAL AND ADMINISTRATIVE EXPENSES 296,201
TOTAL OPERATING EXPENSES 1,161,422
INCOME FROM OPERATIONS 182,884
OTHER INCOME 11,981
INCOME BEFORE INCOME TAXES 194,865
PROVISION FOR INCOME TAXES 27,427
NET INCOME 167,438
COMPREHENSIVE INCOME (LOSS)
Unrealized foreign currency translation loss 3,991
Comprehensive Income 171,429
The accompanying notes are an integral part of
these consolidated financial statements.
RIDGELINE INTERNATIONAL LIMITED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the year ended March 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income $ 167,438
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization 20,516
Gain on disposal of PP&E (765 )
Change in operating assets and liabilities:
Accounts receivable (3,197,132 )
Inventories and biological assets (5,867,528 )
Other receivables 3,778,575
Advances to suppliers (311,821 )
Long-term rent deposit (318,544 )
Other noncurrent assets 4,786
Accounts payable 4,846,064
Other payables and accrued liabilities (16,727 )
Deferred revenue 1,175,581
Taxes payable (93,950 )
Net cash used in operating activities 186,493
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for a subsidiary (109,866 )
Acquisition of equipment (2,138 )
Disposal of PPE 6,791
Additions to leasehold improvements (44,283 )
Net cash used in investing activities (149,496 )
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from notes payable 14,728,487
Repayment of notes payable (14,735,681 )
Proceeds from issuance of shares 121,392
Net cash provided by financing activities 114,198
EFFECT OF EXCHANGE RATE ON CASH (286,229 )
DECREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH (135,034 )
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, beginning of year 5,838,324
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, end of year $ 5,703,290
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for income taxes $ 27,427
The accompanying notes are an integral part of
these consolidated financial statements.
Note 1 - DESCRIPTION OF BUSINESS AND ORGANIZATION
Ridgeline International Limited ("Ridgeline,"
or the "Company") is a Hong Kong company, which is a holding company of Allright (Hangzhou) Internet Technology Co. Ltd ("Allright")
and does not otherwise engage in active operations.
Allright, established in April 2021 with a registered
capital of 10 million Renminbi ("RMB"), is headquartered in Hangzhou, Zhejiang Province. The company operates in the B2B sector,
providing wholesale distribution and online sales through self-operated and third-party platforms, with a focus on pharmaceuticals, medical
devices, health foods, cosmetics, and daily necessities.
The accompanying consolidated financial statements
reflect the activities of the Company and each of the following entities:
Entity Name Background Ownership
Ridgeline Incorporated in Hong Kong SAR on June 27, 2023 Holding
Allright Established in PRC on April 19, 2021 Registered capital of RMB 10 million Carries out pharmaceutical distribution services 100%
Virtually all of the consolidated financial results
(including revenue, profit, assets, and liabilities) are attributable to the operations of Allright. The contributions of other consolidated
entity is immaterial to the Company's financial position and performance.
Note 2 - SUMMARY OF SIGNIFICANT ACCOUNTING
Basis of presentation and consolidation
The accompanying consolidated financial statements
are prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP"). The
consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiaries. All significant inter-company
transactions and balances between the Company and its subsidiaries are eliminated upon consolidation.
The preparation of consolidated financial statements
in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities,
disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses
during the reporting period. The significant estimates made in the preparation of the accompanying consolidated financial statements relate
to the assessment of the carrying values of accounts receivable, related allowance for doubtful accounts, losses. Because of the use of
estimates inherent in the financial reporting process, actual results could materially differ from those estimates.
Fair value measurements
The Company establishes a three-level valuation
hierarchy of valuation techniques based on observable and unobservable inputs, which may be used to measure fair value and include the
Level 1 - Quoted prices in active markets for
identical assets or liabilities.
Level 2 - Inputs other than Level 1 that are observable,
either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active;
or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or
Level 3 - Unobservable inputs that are supported
by little or no market activity and that are significant to the fair value of the assets or liabilities.
Classification within the hierarchy is determined
based on the lowest level of input that is significant to the fair value measurement.
Unless otherwise disclosed, the fair value of
the Company's financial instruments including cash, restricted cash, accounts receivable, advances to suppliers, other current assets,
accounts payable, due to related parties, other current liabilities, short-term bank loans and bank acceptance notes payable approximate
their recorded values due to their short-term maturities. The fair value of longer term long-term bank loan and operating lease liabilities
approximate their recorded values as their stated interest rates approximate the rates currently available.
Long-term investments
Long-term investments include equity investments.
Equity investments include investments in common stock or in-substance common stock of entities. For those equity investments over which
the Company can exercise significant influence but does not own a majority equity interest or control, the equity method is applied, and
the Company adjusts the carrying amount of an investment and recognizes investment income or loss for the Company's share of the
earnings or loss of the investee after the date of investment. For those equity investments accounted for other than under the equity
method, the fair value method is applied. However, for equity investments that do not have readily determinable fair values, the Company
chooses to account for them at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly
transactions for the identical or a similar investment of the same issuer. If this measurement alternative is elected, changes in the
carrying value of the equity investments will be required to be made whenever there are observable price changes in transactions for identical
or similar investments of the same issuer.
Effective March 31, 2023, the Company began recognizing
revenue under Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers ("ASC 606"),

Frequently Asked Questions

What does Ridgeline International Limited do?

Ridgeline is a holding company for Allright, focusing on B2B pharmaceutical distribution.

What is Ridgeline's total assets as of March 31, 2024?

Ridgeline's total assets amount to $17,909,696 as of March 31, 2024.

What was Ridgeline's net income for the year ended March 31, 2024?

Ridgeline reported a net income of $167,438 for the year ending March 31, 2024.

Who audited Ridgeline International Limited?

The audit was conducted by a PCAOB-registered public accounting firm.

What is Ridgeline's total current liabilities?

Ridgeline's total current liabilities stand at $17,704,869.

Last updated: Dec 4, 2025